TUSTIN, Calif., Jan. 6 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that senior management will present at the OneMedForum 2010 Finance Conference on January 13, 2010 at 2:00 p.m. PST. The conference will be held at the Sir Francis Drake Hotel in San Francisco.
A live audio webcast of the company's presentation will be available at the Investors section of Peregrine's website at www.peregrineinc.com.
For more information about this conference, please visit: http://www.onemedplace.com/onemedforum/
About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and serious virus infections. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara®. Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.
Contacts: GendeLLindheim BioCom Partners Investors Media --------- ----- email@example.com Barbara Lindheim (800) 987-8256 (212) 918-4650
SOURCE Peregrine Pharmaceuticals, Inc.